ライフサイエンスコーパス: attorney

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 atus, alcohol use, and the involvement of an attorney.

2 had a living will and/or a medical power of attorney.

3 R order with their physician, family, and/or attorney.

4 were more likely to have a durable power of attorney (34% v 8%, P =.01) and were more likely to have

5 te in research and assign a durable power of attorney (96% scored 2 or less on the Clinical Dementia

6 The durable power of attorney allows research participation for subjects with

7 ad discussed a living will, medical power of attorney, and/or DNR order with their physician, family,

8 by letting administrative law judges, patent attorneys, and a scientific majority decide these cases.

9 e can better communicate with risk managers, attorneys, and insurers; and finally, so that we can bet

10 Durable power of attorney appeared to have substantial weight in OPOs' de

11 in which physician scientists and litigation attorneys assess and utilize clinical evidence.

12 Defense attorneys at the Nuremberg Medical Trial argued that no

13 ions were identified and reviewed by the two attorney authors (L.

14 The author, who is a scientist and an attorney, describes and discusses the fundamental legal

15 , biotech, and food industry leaders; patent attorneys; economists; public and private provider group

16 l genetics have attracted legal interest, as attorneys explore their use in criminal and civil cases.

17 n of (1) living wills, (2) durable powers of attorney for health care (DPAHC), (3) patient-physician

18 panding the legal scope of durable powers of attorney for health care may have a significant impact.

19 Subjects who had assigned a durable power of attorney for health care were less likely to die in a ho

20 defined as having a living will, a power of attorney for health care, or life-support instructions.

21 ects who had not assigned a durable power of attorney for health care.

22 essing need shared by researchers and patent attorneys from different chemical disciplines.

23 e negotiation with the Office of the Vermont Attorney General and manual photocopying of individual d

24 Attorney General Consumer and Prescriber Education grant

25 National Cancer Institute and Attorney General Consumer and Prescriber Education Progr

26 n agreement signed in 1998 between the state attorneys general and tobacco companies, ended payments

27 In 1998, the attorneys general of 46 states signed a Master Settlemen

28 of worker's compensation who did not hire an attorney had generally good outcomes.

29 Attorneys have begun to sue on behalf of individuals exp

30 linchpin is assignment of a durable power of attorney in the early-to-moderate stage of Alzheimer's d

31 observer reliability between the two raters (attorneys) in interpretation of six items characterizing

32 us, mental health status, health habits, and attorney involvement prior to performing carpal tunnel r

33 ng a living will, 46% had a medical power of attorney (n = 98), and 19% had a do-not-resuscitate (DNR

34 rs presented themselves voluntarily to state attorney offices.

35 ans, epidemiologists, patient advocates, and attorneys participated in the workshop, which was conven

36 will, and health care proxy/durable power of attorney), positive religious coping remained a signific

37 An attorney rated the legislation as giving most direction

38 The two attorney raters found the description of acceptable outc

39 Among workers, involvement of an attorney was significantly associated with greater funct

40 he holder of the deceased's durable power of attorney, whereas only 7 (11%) reported they were likely

41 surrogate consent through a durable power of attorney would become necessary to facilitate continued

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。